5AM Opportunities I (GP), LLC

10% owner at Cabaletta Bio, Inc. · on record since Oct 31, 2019
10% owner at Aprea Therapeutics, Inc. · on record since Oct 9, 2019
See Remarks at scPharmaceuticals Inc. · on record since May 28, 2020
10% owner at Akouos, Inc. · on record since Jun 25, 2020
10% owner at IDEAYA Biosciences, Inc. · on record since Nov 13, 2020
Former 10% holder at Aprea Therapeutics, Inc. · on record since Oct 7, 2020
10% owner at Rallybio Corp · on record since Jul 29, 2021
10% owner at Vor Biopharma Inc. · on record since Feb 9, 2021
10% owner at IMPERIAL INDUSTRIES INC · on record since Apr 29, 2021
10% owner at Entrada Therapeutics, Inc. · on record since Oct 28, 2021
10% owner at Pear Therapeutics, Inc. · on record since Dec 13, 2021
10% owner at CinCor Pharma, Inc. · on record since Jan 13, 2022
10% owner at scPharmaceuticals Inc. · on record since Apr 13, 2022
10% owner at Enliven Therapeutics, Inc. · on record since Mar 6, 2023

Insider trading activity of 5AM Opportunities I (GP), LLC

Transactions on record: 32; since Jun 18, 2020

Open-market buys: 3; $15M

Open-market sells: 15; $19M

Companies traded: 6; last filing Feb 2, 2024

Figures computed from official regulatory filings — .

Companies where 5AM Opportunities I (GP), LLC has traded

Enliven Therapeutics, Inc.2 tx · $7.5M · Feb 2, 2024
Pear Therapeutics, Inc.6 tx · $1M · Sep 16, 2022
3 tx · $1.4M · Apr 13, 2022
8 tx · $10M · Feb 9, 2021
4 tx · $9.1M · Oct 7, 2020
9 tx · $5M · Jul 2, 2020

Track record of 5AM Opportunities I (GP), LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of 5AM Opportunities I (GP), LLC

Co-insiders of 5AM Opportunities I (GP), LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Feb 2, 2024	Sell	-82,813	15.00 USD	$1.2M		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 2, 2024	Sell	-417,187	15.00 USD	$6.3M	Unusual size	SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-10,910	1.81 USD	$19.7K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-14	1.75 USD	$24.5		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-11,403	1.94 USD	$22.1K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-273,664	1.94 USD	$530.9K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-337	1.75 USD	$589.8		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-261,840	1.81 USD	$473.9K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-9,171	5.00 USD	$45.9K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-40,733	5.00 USD	$203.7K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-220,096	5.00 USD	$1.1M		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	3,308,822	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-45,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-19,230,768	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	1,414,026	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Buy	111,111	18.00 USD	$2M	conv 39Cluster	SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	1,414,026	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Buy	444,444	18.00 USD	$8M	conv 51Cluster	SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-19,230,768	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2020	Sell	-175,000	25.30 USD	$4.4M		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-21,072,595	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	Other	1,997,946	—	n/a (No price was disclosed in the filing)		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-16,858,076	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	Buy	294,117	17.00 USD	$5M	conv 57ClusterFirst in 12mo	SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-42,102,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Feb 2, 2024	Sell	-82,813	15.00 USD	$1.2M		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 2, 2024	Sell	-417,187	15.00 USD	$6.3M	Unusual size	SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-10,910	1.81 USD	$19.7K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-14	1.75 USD	$24.5		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-11,403	1.94 USD	$22.1K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-273,664	1.94 USD	$530.9K		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-337	1.75 USD	$589.8		SEC
Pear Therapeutics, Inc.Listing unverified	Sep 16, 2022	Sell	-261,840	1.81 USD	$473.9K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-9,171	5.00 USD	$45.9K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-40,733	5.00 USD	$203.7K		SEC
scPharmaceuticals Inc.Listing unverified	Apr 13, 2022	Sell	-220,096	5.00 USD	$1.1M		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	3,308,822	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-45,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-19,230,768	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	1,414,026	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Buy	111,111	18.00 USD	$2M	conv 39Cluster	SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	1,414,026	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Buy	444,444	18.00 USD	$8M	conv 51Cluster	SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-19,230,768	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2020	Sell	-175,000	25.30 USD	$4.4M		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-21,072,595	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	Other	1,997,946	—	n/a (No price was disclosed in the filing)		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-16,858,076	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	Buy	294,117	17.00 USD	$5M	conv 57ClusterFirst in 12mo	SEC
Akouos, Inc.Listing unverified	Jul 2, 2020	OtherD (derivative)	-42,102,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC